The first biologic drug to treat moderate-to-severe eczema in infants and children was highly effective in reducing symptoms, according to a recent study.
Menu
Browsing: Clinical Breakthroughs
A two-drug combination has been shown to improve patient response to treatment in relapsed or refractory acute myeloid leukemia.
After a pediatric cancer diagnosis, chances of infections remain elevated for more than a decade, according to a recent study.
Northwestern Memorial Hospital was recently ranked seventh in the country for Gastroenterology & Gastrointestinal (GI) surgery by US News and World Report. This article was originally published in August 2022 Breakthroughs.
Polygenic risk scores demonstrated minimal clinical benefit in predicting long-term coronary heart disease when added to a traditional risk factor model, according to a Northwestern Medicine study.
Northwestern University has been awarded a seven-year grant to study a “pill-in-pocket” strategy to prevent stroke in patients with atrial fibrillation, the most common heart rhythm disorder in adults.
Geography played a role in opioid-involved overdose deaths in the past, but a coming wave may discriminate between rural and urban areas, according to a recent study.
Metformin, a common, safe and inexpensive drug for type 2 diabetes, lowered the odds of emergency department visits, hospitalizations or death due to COVID-19 by over 40 percent, according to a new multi-site clinical trial.
A new Northwestern Medicine trial will test whether a telehealth-based intervention that addresses three behavioral risk factors at once can modify cancer patients’ lifestyles to improve their outcomes.
Bigger test panels are better for genetic testing in cardiomyopathy and heart arrhythmias, according to a recent Northwestern Medicine study.